share_log

ZIVO Bioscience (NASDAQ:ZIVOW) Trading Down 2.4%

Defense World ·  Mar 11, 2023 03:26

ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) shares fell 2.4% during trading on Friday . The company traded as low as $0.73 and last traded at $0.83. 1,107 shares were traded during trading, a decline of 79% from the average session volume of 5,230 shares. The stock had previously closed at $0.85.

ZIVO Bioscience Trading Down 2.4 %

The business's 50-day moving average price is $0.79 and its 200 day moving average price is $0.77.

Get ZIVO Bioscience alerts:

Institutional Inflows and Outflows

A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC lifted its stake in shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 84,654 shares of the company's stock after acquiring an additional 69,034 shares during the period. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent SEC filing.

About ZIVO Bioscience

(Get Rating)

ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.

Further Reading

  • Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
  • 2 Offshore Drilling Stocks Set to Extract Big Profits
  • Three Staples Stocks With Double-Digit Upside Ahead
  • Can Investors Trust Consumers to Lift American Outdoor Brands?
  • How to Buy High Yielding Dividend Stocks
  • Oracle Has Spoken: Shares Fall 5%

Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment